Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8006)
All Articles published online
|
Publishing Process of This Article
|
Jan 15, 2022 (publication date) through May 23, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sun HY, Du ST, Li YY, Deng GT, Zeng FR. Bromodomain and extra-terminal inhibitors emerge as potential therapeutic avenues for gastrointestinal cancers. World J Gastrointest Oncol 2022; 14(1): 75-89 [PMID: 35116104 DOI: 10.4251/wjgo.v14.i1.75] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v14/i1/75.htm |
| Number | Citing Articles |
| 1 |
Masahiro Hashimoto, Takaaki Masuda, Yusuke Nakano, Taro Tobo, Hideyuki Saito, Kensuke Koike, Junichi Takahashi, Tadashi Abe, Yuki Ando, Yuki Ozato, Kiyotaka Hosoda, Satoshi Higuchi, Yuichi Hisamatsu, Takeo Toshima, Yusuke Yonemura, Tsuyoshi Hata, Mamoru Uemura, Hidetoshi Eguchi, Yuichiro Doki, Masaki Mori, Koshi Mimori. Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer. Cancer Science 2024; 115(6): 1866 doi: 10.1111/cas.16129
|
| 2 |
Maria Vieito, Matteo Simonelli, Filip de Vos, Victor Moreno, Marjolein Geurts, Elena Lorenzi, Marina Macchini, Martin J van den Bent, Gianluca Del Conte, Maja de Jonge, Maria Cruz Martín-Soberón, Barbara Amoroso, Tania Sanchez-Perez, Marlene Zuraek, Bishoy Hanna, Ida Aronchik, Ellen Filvaroff, Henry Chang, Cristina Mendez, Marina Arias Parro, Xin Wei, Zariana Nikolova, Juan Manuel Sepulveda. Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma. Neuro-Oncology Advances 2022; 4(1) doi: 10.1093/noajnl/vdac146
|
| 3 |
Kun Wang, Jiatong Tang, Shengxian Fan, Haochen Su, Ranran Yu, Yixuan Zhang, Hao Wu, Ying Lv, Shu Zhang, Xiaoping Zou. ABBV-744 induces autophagy in gastric cancer cells by regulating PI3K/AKT/mTOR/p70S6k and MAPK signaling pathways. Neoplasia 2023; 45: 100936 doi: 10.1016/j.neo.2023.100936
|
| 4 |
Moumita Kundu, Ramesh Butti, Venketesh K. Panda, Diksha Malhotra, Sumit Das, Tandrima Mitra, Prachi Kapse, Suresh W. Gosavi, Gopal C. Kundu. Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer. Molecular Cancer 2024; 23(1) doi: 10.1186/s12943-024-01990-4
|
| 5 |
Nguyen T.B. Nguyen, Sira Gevers, Rutger N.U. Kok, Lotte M. Burgering, Hannah Neikes, Ninouk Akkerman, Max A. Betjes, Marlies C. Ludikhuize, Can Gulersonmez, Edwin C.A. Stigter, Yvonne Vercoulen, Jarno Drost, Hans Clevers, Michiel Vermeulen, Jeroen S. van Zon, Sander J. Tans, Boudewijn M.T. Burgering, Maria J. Rodríguez Colman. Lactate controls cancer stemness and plasticity through epigenetic regulation. Cell Metabolism 2025; 37(4): 903 doi: 10.1016/j.cmet.2025.01.002
|
| 6 |
Mengying Zhang, Hong Huang, Meijiao Wei, Mengjia Sun, Guojin Deng, Shuiqing Hu, Hongbo Wang, Yanling Gong. Overexpression of BRD4 in Gastric Cancer and its Clinical Significance as
a Novel Therapeutic Target. Current Cancer Drug Targets 2024; 24(2): 167 doi: 10.2174/1568009623666230606164030
|
| 7 |
Yu-Hsuan Hung, Hui-Ching Wang, Mei-Ren Pan, Li-Tzong Chen. Chromatin Remodeling-Related PRDM1 Increases Stomach Cancer Proliferation and Is Counteracted by Bromodomain Inhibitor. Journal of Personalized Medicine 2024; 14(3): 224 doi: 10.3390/jpm14030224
|
| 8 |
Magdalena Strachowska, Karolina Gronkowska, Maciej Sobczak, Marika Grodzicka, Sylwia Michlewska, Kinga Kołacz, Tuhin Sarkar, Joanna Korszun, Maksim Ionov, Agnieszka Robaszkiewicz. I-CBP112 declines overexpression of ATP-binding cassette transporters and sensitized drug-resistant MDA-MB-231 and A549 cell lines to chemotherapy drugs. Biomedicine & Pharmacotherapy 2023; 168: 115798 doi: 10.1016/j.biopha.2023.115798
|
| 9 |
Furong Zeng, Yayun Li, Yu Meng, Huiyan Sun, Yi He, Mingzhu Yin, Xiang Chen, Guangtong Deng. BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression. Experimental & Molecular Medicine 2023; 55(2): 364 doi: 10.1038/s12276-023-00936-y
|
| 10 |
Jiajie Ren. Bromodomain‐containing protein 4 inhibition improves the efficacy of cisplatin and radiotherapy in oral squamous cell carcinoma by suppressing programmed cell death‐ligand 1 expression. Basic & Clinical Pharmacology & Toxicology 2024; 134(2): 272 doi: 10.1111/bcpt.13962
|
| 11 |
Manoj Kumar Gupta, Gayatri Gouda, Maryam Moazzam-Jazi, Ramakrishna Vadde, Ganji Purnachandra Nagaraju, Bassel F. El-Rayes. CRISPR/Cas9-directed epigenetic editing in colorectal cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2025; 1880(3): 189338 doi: 10.1016/j.bbcan.2025.189338
|
| 12 |
Isilay Gultekin, Erva Ozkan, Filiz Bakar‐Ates, Oya Bozdag‐Dundar. New Flavone Derivatives Targeting BET Proteins in Cancer: Synthesis, Structure Analysis and Investigation of Bromodomain Inhibitory Activities**. ChemistrySelect 2023; 8(41) doi: 10.1002/slct.202302492
|
| 13 |
Martina Parente, Claudia Tonini, Marco Segatto, Valentina Pallottini. Regulation of cholesterol metabolism: New players for an old physiological process. Journal of Cellular Biochemistry 2023; 124(10): 1449 doi: 10.1002/jcb.30477
|